NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Nanobiotix S.A (F: 5NR)
5NR Technical Analysis
2
As on 11th Jul 2023 5NR STOCK Price closed @ 5.56 and we RECOMMEND Buy for LONG-TERM with Stoploss of 4.84 & Strong Sell for SHORT-TERM with Stoploss of 6.92 we also expect STOCK to react on Following IMPORTANT LEVELS. |
5NRSTOCK Price
Open | 5.56 | Change | Price | % |
High | 5.56 | 1 Day | -1.03 | -15.63 |
Low | 5.56 | 1 Week | 0.85 | 18.05 |
Close | 5.56 | 1 Month | 0.98 | 21.40 |
Volume | 540 | 1 Year | -2.33 | -29.53 |
52 Week High 7.99 | 52 Week Low 1.69 |
F Germany Most Active Stocks
ENB | 47.60 | -0.92% |
TEF | 3.84 | -0.52% |
TEF | 3.84 | -0.52% |
WHL | 5150.00 | -0.44% |
WDI | 0.05 | -37.50% |
WDI | 0.05 | -37.50% |
WDI | 0.05 | -37.50% |
WDI | 0.05 | -37.50% |
WDI | 0.05 | -37.50% |
TOE | 0.02 | 0.00% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
5NR Daily Charts |
5NR Intraday Charts |
Whats New @ Bazaartrend |
5NR Free Analysis |
|
5NR Important Levels Intraday
RESISTANCE | 5.56 |
RESISTANCE | 5.56 |
RESISTANCE | 5.56 |
RESISTANCE | 5.56 |
RESISTANCE | 5.56 |
RESISTANCE | 5.56 |
RESISTANCE | 5.56 |
RESISTANCE | 5.56 |
5NR Forecast May 2024
4th UP Forecast | 9.8 |
3rd UP Forecast | 8.44 |
2nd UP Forecast | 7.6 |
1st UP Forecast | 6.76 |
1st DOWN Forecast | 4.36 |
2nd DOWN Forecast | 3.52 |
3rd DOWN Forecast | 2.68 |
4th DOWN Forecast | 1.32 |
5NR Weekly Forecast
4th UP Forecast | 7.54 |
3rd UP Forecast | 6.91 |
2nd UP Forecast | 6.51 |
1st UP Forecast | 6.12 |
1st DOWN Forecast | 5.00 |
2nd DOWN Forecast | 4.61 |
3rd DOWN Forecast | 4.21 |
4th DOWN Forecast | 3.58 |
5NR Forecast2024
4th UP Forecast | 17.7 |
3rd UP Forecast | 13.81 |
2nd UP Forecast | 11.4 |
1st UP Forecast | 8.99 |
1st DOWN Forecast | 2.13 |
2nd DOWN Forecast | -0.28 |
3rd DOWN Forecast | -2.69 |
4th DOWN Forecast | -6.58 |
Nanobiotix S.A ( F Germany Symbol : 5NR )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
5NR Other Details
Segment | EQ | |
Market Capital | 333806240.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
5NR Address
5NR Latest News
5NR Business Profile
Nanobiotix S.A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer. The company develops NanoXray products to help patients receiving radiotherapy by enhancing the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. It offers NBTXR3, a sterile aqueous suspension of functionalized crystalline hafnium oxide nanoparticles used for the treatment of solid tumors, including soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, and non-small cell lung cancer. Nanobiotix S.A. has a partnership with LianBio to develop and commercialize NBTXR3 in Greater China, South Korea, Singapore, and Thailand. The company was incorporated in 2003 and is headquartered in Paris, France. Address: 60 rue de Wattignies, Paris, France, 75012
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service